Superpower announces partnership with GRAIL
Members access Galleri blood test detecting over 50 cancers. It predicts cancer origin for diagnostics.
See the latest news and media coverage for Superpower. We track all announcements, press releases, and industry mentions in real time, all in one place.
Preventive biomarker testing and personalized care membership
superpower.comLast updated
In short: Superpower expanded its proactive health platform through strategic partnerships, a major acquisition, and the launch of AI-driven wellness tools.
Members access Galleri blood test detecting over 50 cancers. It predicts cancer origin for diagnostics.
Early-onset cancers increase 80% since 1990. Advocates proactive multi-cancer blood tests like Galleri for early detection. Lifestyle changes reduce risks.
The test detects cancer signals from cell-free DNA across 50+ types early, shifting screening from reactive to proactive. It advances Superpower's health mission.
It combines personal health data, medical research, and clinical reasoning for trusted, personalized guidance. Human clinicians review and improve the AI weekly.
Attracting outside investment remains a core policy and a central part of his plan to build Antigua and Barbuda into a “lifestyle superpower” − one...
Healthcare, as we’ve known it for decades, has largely been built around a simple premise: you seek help when something goes wrong. Symptoms appear, you...
GRAIL (GRAL) is back in focus after a run of integration deals that plug its Galleri multi cancer early detection blood test into Epic electronic...
David French and Rep. Suhas Subramanyam join Tim Miller. Tix on sale soon for The Bulwark LIVE in San Diego on May 20 and in...
Track Superpower and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Superpower and other trending companies.